Biotech Values

[mcbio]

After the problems with Avastin using PFS in breast cancer, aren't regulatory authorities going to take a very hard look at Avastin using PFS in another cancer indication?

Apparently not EU authorities given the CHMP recommendation. To be fair, I think the ovarian cancer patients being targeted here are much more of an unmet need.